Evidence map›Paper›PMID 27788929›Full record

ArticleThe Journal of pediatrics2017

Circulating Inflammatory-Associated Proteins in the First Month of Life and Cognitive Impairment at Age 10 Years in Children Born Extremely Preterm.

Karl C K Kuban, Robert M Joseph, Thomas M O'Shea, Timothy Heeren, Raina N Fichorova, Laurie Douglass, Hernan Jara, Jean A Frazier, Deborah Hirtz, Julie Vanier Rollins and 2 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The Journal of pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Intermittent hypoxia and caffeine in infants born preterm: the ICAF Randomized Clinical Trial.Archives of disease in childhood. Fetal and neonatal edition · 2026
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Karl C K KubanDepartment of Pediatrics, Boston Medical Center, Boston, MA. Electronic address: karl.kuban@bmc.org.
Robert M JosephDepartment of Anatomy and Neuroanatomy, Boston University School of Medicine, Boston, MA.
Thomas M O'SheaDepartment of Pediatrics, Division of Neonatal-Perinatal Medicine, University of North Carolina, Chapel Hill, NC.
Timothy HeerenDepartment of Biostatistics, Boston University School of Public Health, Boston, MA.
Raina N FichorovaLaboratory of Genital Tract Biology, Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Laurie DouglassDepartment of Pediatrics, Boston Medical Center, Boston, MA.
Hernan JaraDepartment of Radiology, Boston University School of Medicine, Boston, MA.
Jean A FrazierDepartment of Psychiatry, University of Massachusetts Medical School/ University of Massachusetts Memorial Health Care, Worcester, MA.
Deborah HirtzNational Institute of Neurological Disorders and Stroke, Bethesda, MD.
Julie Vanier RollinsDepartment of Pediatrics, Boston Medical Center, Boston, MA.
Nigel PanethDepartment of Epidemiology and Biostatistics and Pediatrics, Michigan State University, East Lansing, MI.
Extremely Low Gestational Age Newborn (ELGAN) Study Investigators
Boston Medical Center · USBoston University · USBrigham and Women's Hospital · USMichigan State University · USNational Institute of Neurological Disorders and Stroke · USUniversity of Massachusetts Chan Medical School · USUniversity of North Carolina at Chapel Hill · US

Funding

Neonatal Biomarkers in Extremely Preterm Babies Predict Childhood Brain DisordersU01NS040069 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI KUBAN, KARL · 2001 to 2014
$34.0M
SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
NICHD NIH HHS P30 HD018655NINDS NIH HHS U01 NS040069
6 · The paper itself

Abstract

objectivesTo evaluate whether in children born extremely preterm, indicators of sustained systemic inflammation in the first month of life are associated with cognitive impairment at school age. STUDY

designA total of 873 of 966 eligible children previously enrolled in the multicenter Extremely Low Gestational Age Newborn Study from 2002 to 2004 were evaluated at age 10 years. We analyzed the relationship between elevated blood concentrations of inflammation-associated proteins in the first 2 weeks ("early elevations"; n = 812) and the third and fourth week ("late elevations"; n = 532) of life with neurocognition.

resultsEarly elevations of C-reactive protein, tumor necrosis factor-α, interleukin (IL)-8, intercellular adhesion molecule (ICAM)-1, and erythropoietin were associated with IQ values >2 SD below the expected mean (ORs: 2.0-2.3) and with moderate to severe cognitive impairment on a composite measure of IQ and executive function (ORs: 2.1-3.6). Additionally, severe cognitive impairment was associated with late protein elevations of C-reactive protein (OR: 4.0; 95% CI 1.5, 10), IL-8 (OR: 5.0; 1.9, 13), ICAM-1 (OR: 6.5; 2.6, 16), vascular endothelial growth factor-receptor 2 (OR: 3.2; 1.2, 8.3), and thyroid-stimulating hormone (OR: 3.1; 1.3, 7.3). Moderate cognitive impairment was most strongly associated with elevations of IL-8, ICAM-1, and vascular endothelial growth factor-receptor 2. When 4 or more inflammatory proteins were elevated early, the risk of having an IQ <70 and having overall impaired cognitive ability was more than doubled (ORs: 2.1-2.4); the presence of 4 or more inflammatory protein elevated late was strongly linked to adverse cognitive outcomes (ORs: 2.9-4.8).

conclusionsExtremely preterm children who had sustained elevations of inflammation-related proteins in the first postnatal month are more likely than extremely preterm peers without such elevations to have cognitive impairment at 10 years.

Indexed as

ChildCognitive DysfunctionC-Reactive ProteinErythropoietinFemaleHumansInfant, Extremely PrematureInfant, NewbornInflammationIntercellular Adhesion Molecule-1Interleukin-8MaleProspective StudiesVascular Endothelial Growth Factor AC-Reactive ProteinCXCL8 protein, humanErythropoietinIntercellular Adhesion Molecule-1Interleukin-8Vascular Endothelial Growth Factor Acognitionextremely preterm infantsinflammation-related proteinsschool age

Identifiers

PMID27788929
PMCPMC5183478
OpenAlexW2535391239

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.